Actinium Pharmaceuticals Inc (ATNM)
1.9200 x 13 1.9500 x 3
Post-market by (Cboe BZX)
1.8700 +0.2900 (+18.35%) 03/26/25 [NYSE Arca]
1.9200 x 13 1.9500 x 3
Post-market 1.9400 +0.0700 (+3.74%) 18:01 ET
for Wed, Mar 26th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 81 | 1,030 | 1,144 | 0 | 0 |
| Gross Profit | 81 | 1,030 | 1,144 | N/A | N/A |
| Operating Expenses | 52,001 | 35,134 | 26,108 | 22,393 | 22,072 |
| Operating Income | -51,920 | -34,104 | -24,964 | -22,393 | -22,072 |
| Other Income | 3,102 | 1,087 | 190 | 178 | 172 |
| Pre-tax Income | -48,818 | -33,017 | -24,774 | -22,215 | -21,900 |
| Net Income Continuous | -48,818 | -33,017 | -24,774 | -22,215 | -21,900 |
| Net Income | $-48,818 | $-33,017 | $-24,774 | $-22,215 | $-21,900 |
| EPS Basic Total Ops | -1.83 | -1.37 | -1.20 | -1.83 | -4.40 |
| EPS Basic Continuous Ops | -1.84 | -1.37 | -1.20 | -1.83 | -4.40 |
| EPS Diluted Total Ops | -1.83 | -1.37 | -1.20 | -1.83 | -4.40 |
| EPS Diluted Continuous Ops | -1.84 | -1.37 | -1.20 | -1.83 | -4.40 |
| EPS Diluted Before Non-Recurring Items | -1.83 | -1.37 | N/A | -1.83 | N/A |
| EBITDA(a) | $-51,130 | $-33,405 | $-24,440 | $-21,946 | $-21,652 |